Director, Portfolio Omnichannel (Lung HCP)

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This newly created role represents a unique opportunity to shape the future of HCP engagement at Revolution Medicines. The Portfolio Omnichannel Strategy Operations Team is seeking a forward-thinking, digitally fluent marketing operations leader to drive optimal performance while also delivering high-quality customer experiences across our HCP engagement channels.

The Director, Portfolio Omnichannel Strategy Operations (Oncology Lung HCP) is a highly collaborative leader focused on both strategy execution and is responsible for partnering with Brand Commercial function Leads in translating oncology brand strategies into high-impact, compliant, and innovative customer engagement experiences. This leader will define and socialize the strategy and approach to successfully pull through Lung’s portfolio of customer engagement ambitions (aligned to the brand’s strategic imperatives, objectives and key measures). In a fast-paced, growth-stage biotech environment, this role serves as the connector between strategy and execution partnering cross-functionally to operationalize omnichannel campaigns with precision, agility, and measurable impact.

This leader will help build scalable capabilities, optimize customer journeys, and elevate omnichannel maturity as the organization prepares for commercialization and further portfolio growth through in-line brands commercial launches. Along with leading the strategic discipline across Lung Omnichannel (above), this individual is also a subject matter expert in HCP marketing channels and their optimization for brand impact. The role is ideal for someone who thrives in balancing strategic thinking with hands-on impacts to operational excellence, and is motivated by building best-in-class engagement models in oncology.

This role reports to the Executive Director, Omnichannel Portfolio Strategy Operations. Note: Branded Unbranded HCP Marketing strategy, imperatives, objectives content will be created by the brand aligned Marketing Business Lead(s) and/or as output from the brand plan. This role acts as trusted counsel to the brand team and focuses on the enablement optimization of such imperatives (for both specific and across channels).

Key Responsibilities

: Strategic Omnichannel Enablement Lung Omnichannel Program Lead: Manage (capability, innovation, delivery, risks opportunities and socialization for the overall Lung marketing strategy where it intersects with Omnichannel (all channels). Omnichannel capability lead for all Lung Assets / Tumors: Partner with Brand(s), Sales, REIDS (RML type KOL focused role), Market Access, Patient Access and Medical to plan operationalize independent integrated oncology HCP customer engagement strategies. Partner with Brand HCP Leads to develop and execute comprehensive marketing plan for all oncology Lung launch products and indications, including creating strategic proposals and actionable options for effectively targeting HCP via function, campaign content.

Define the Lung Omnichannel operational strategy and the accountability of its effectiveness. Translate strategic plans into executable measurable customer journeys across personal and non-personal channels driving optimal product utilization.